|44.32||-0.71 / -1.58%|
As of 4:02pm ET
|44.83||+0.51 / +1.15%|
The 9 analysts offering 12-month price forecasts for Wuxi Pharmatech Cayman Inc have a median target of 42.00, with a high estimate of 51.00 and a low estimate of 35.00. The median estimate represents a -5.23% decrease from the last price of 44.32.
The current consensus among 11 polled investment analysts is to Hold stock in Wuxi Pharmatech Cayman Inc. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.